Accelerating Plasmid Production by Optimizing Your Process Analytics
The global demand for plasmid DNA has risen dramatically in the recent years, largely driven by the unprecedented growth in cell and gene therapy. The success in these therapies has increased demand for plasmid DNA used to produce viral vectors, both in quantities for commercial products, as well as for early development programs. In addition, the current situation with COVID-19 has further increased the demand for adenovirus-based or mRNA vaccines, for which pDNA is also the starting material. Unfortunately, scaling up manufacturing capacity for pDNA is complicated and has become a bottleneck for the industry. Plasmid DNA manufacturers that are looking for ways to accelerate production and confirm high quality product are encouraged to sign up for this webinar. We will share a platform process that will eliminate sample dilution and accurately measure DNA purity ratios in less than 5 minutes with an Rvalue accuracy of less than 2% deviation for all 25 sampling percentages. Slope spectroscopy has proven to be a critical analytical method, expediting the testing of challenging samples, providing immediate feedback, and opening up multiple possibilities for meeting your process needs.
- Understand slope spectroscopy using variable pathlength technology (VPT) and how it's different from traditional fixed pathlength spectroscopy.
- Discuss strategies to accelerate production by optimizing process analytics for plasmid concentration and purity assessments by reducing time/manpower requirements.
- Real world experience showing how Pfizer implemented VPT for plasmid DNA purity ratio testing in their human gene therapy product (Pfizer case study)
- Overview of other gene therapy applications using the SoloVPE System
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Precision in production: optimizing monitoring and quality control for high-value plasmids
Advancing cell therapy: innovations in polymer-based encapsulation and delivery
Pure and simple: understanding LNP analytics for better mRNA-based drugs
